1999
DOI: 10.1002/(sici)1097-0215(19990827)82:5<678::aid-ijc10>3.0.co;2-k
|View full text |Cite
|
Sign up to set email alerts
|

Malignant rhabdoid-tumor cell line showing neural and smooth-muscle-cell phenotypes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
37
0

Year Published

2001
2001
2019
2019

Publication Types

Select...
6
2

Relationship

2
6

Authors

Journals

citations
Cited by 33 publications
(38 citation statements)
references
References 23 publications
(27 reference statements)
1
37
0
Order By: Relevance
“…Although several immunohistochemical studies with single-labeling methods have reported coexpression of cytokeratin and vimentin, no clear localization of these intermediate filaments in cytoplasm has been clarified (9,10,13,17,18). With regard to cytokeratin subunits, Shiratsuchi et al (18) reported that all six cases of MRT diffusely expressed CKs 8 and 18.…”
Section: Discussionsupporting
confidence: 65%
See 1 more Smart Citation
“…Although several immunohistochemical studies with single-labeling methods have reported coexpression of cytokeratin and vimentin, no clear localization of these intermediate filaments in cytoplasm has been clarified (9,10,13,17,18). With regard to cytokeratin subunits, Shiratsuchi et al (18) reported that all six cases of MRT diffusely expressed CKs 8 and 18.…”
Section: Discussionsupporting
confidence: 65%
“…Also, expression of CKs 8 and 18 is observed in some malignant mesenchymal tumors such as leiomyosarcoma and malignant peripheral nerve sheath tumor (20), in addition to epithelioid sarcoma and synovial sarcoma (20,21), which are classified as miscellaneous tumors. Therefore, the (6,17), epithelial (10,22), myogenic (10,23), and smooth-muscle-cell (16) phenotype. Whatever its pathogenesis may be, the relatively uniform clinicopathological profile of MRT supports its acceptance as a specific disease entity of malignancy.…”
Section: Discussionmentioning
confidence: 99%
“…About 13 MRT cell lines have been documented (12,13). The expression of EGFR on MRT cell lines was shown by immunohistochemistry and cell growth inhibition by anti-EGFR antibody (14).…”
Section: Introductionmentioning
confidence: 97%
“…However, the expression of EGFR on MRT tissues and the phosphorylation of EGFR by epidermal growth factor (EGF) on MRT cell lines have never been examined. We established two MRT cell lines from two MRT patients (13,15). In this study, we confirm the genetic diagnoses of these cell lines to MRT by the alteration of INI1 gene (16).…”
Section: Introductionmentioning
confidence: 99%
“…Various cellular origins of MRT, such as neuroectodermal (8,9,12), neural (13)(14)(15), epithelial (16), histiocytic (17) or myogenic (18), have been proposed. Despite the variability observed in tumor location and histology, most rhabdoid tumors share a similar genetic origin and are characterized by the presence of mutations in the hSNF5/INI1 gene on chromosome band 22q11.2 (19)(20)(21).…”
Section: Introductionmentioning
confidence: 99%